OSTEOSARCOMA
Clinical trials for OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug cabozantinib tested in kids and young adults with bone cancer
Disease control TerminatedThis study tested the drug cabozantinib in children, teens, and young adults with osteosarcoma (a bone cancer) that could not be fully removed by surgery. Participants who had stable or partially improved disease after chemotherapy received either cabozantinib plus best supportiv…
Matched conditions: OSTEOSARCOMA
Phase: PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental combo targets Hard-to-Treat bone cancer
Disease control TerminatedThis early-phase trial tested a combination of two drugs—TQB2928 (an antibody that helps the immune system attack cancer cells) and anlotinib (a drug that cuts off tumor blood supply)—in 20 people with advanced osteosarcoma or other solid tumors that had stopped responding to sta…
Matched conditions: OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC